Financials data is unavailable for this security.
View more
Year on year IND Swift Laboratories Ltd grew revenues 6.10% from 12.07bn to 12.81bn while net income improved 784.43% from 475.97m to 4.21bn.
Gross margin | 47.54% |
---|---|
Net profit margin | 40.36% |
Operating margin | 52.91% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, IND Swift Laboratories Ltd increased its cash reserves by 2,270.79%, or 4.13bn. Cash Flow from Financing totalled 6.99bn or 54.56% of revenues. In addition the company used 1.81bn for operations while cash used for investing totalled 1.04bn.
Cash flow per share | 75.50 |
---|---|
Price/Cash flow per share | 1.79 |
Book value per share | -- |
---|---|
Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼